Methodological aspects of international drug price comparisons.

作者: F. Andersson

DOI: 10.2165/00019053-199304040-00003

关键词:

摘要: Drug prices have become an important issue in the last few years as concerns about constrained healthcare resources increased. Healthcare authorities all industrialised countries are questioning whether their country is carrying a heavier burden than others paying for drugs. In view of this discussion, several price comparison studies been conducted. However, there no generally accepted methodology on how to conduct comparisons, and many methodological issues remain unresolved. The results most published affected by moderately serious flaws. which never properly addressed.

参考文章(4)
F. Andersson, Discourse on GAO drug price comparisons. Health Affairs. ,vol. 12, pp. 220- 221 ,(1993) , 10.1377/HLTHAFF.12.2.220-A
Ulf-G. Gerdtham, Bengt Jönsson, Conversion factor instability in international comparisons of health care expenditure. Journal of Health Economics. ,vol. 10, pp. 227- 234 ,(1991) , 10.1016/0167-6296(91)90005-8
David L. Cleeton, Valy T. Goepfrich, Burton A. Weisbrod, What does the Consumer Price Index for prescription drugs really measure Health Care Financing Review. ,vol. 13, pp. 45- 51 ,(1992)
W. Duncan Reekie, Price Comparisons of Identical Products in Japan, the United States and Europe Research Papers in Economics. pp. 168- 181 ,(1983) , 10.1007/978-1-349-17099-9_9